BioGaia AB (publ) (BIOG-B.ST)
SEK 110.5
(0.82%)
SEK 110.5
(0.82%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 3.62 SEK | -2.16% |
| 2022 | 3.70 SEK | 90.72% |
| 2021 | 1.94 SEK | 8.99% |
| 2020 | 1.78 SEK | -17.59% |
| 2019 | 2.16 SEK | -12.9% |
| 2018 | 2.48 SEK | 19.23% |
| 2017 | 2.08 SEK | -20.91% |
| 2016 | 2.63 SEK | 87.86% |
| 2015 | 1.40 SEK | -18.13% |
| 2014 | 1.71 SEK | 140.85% |
| 2013 | 0.71 SEK | -81.27% |
| 2012 | 3.79 SEK | 330.68% |
| 2011 | 0.88 SEK | 60.0% |
| 2010 | 0.55 SEK | 30.95% |
| 2009 | 0.42 SEK | 0.0% |
| 2008 | 0.42 SEK | 82.61% |
| 2007 | 0.23 SEK | 618.75% |
| 2006 | 0.03 SEK | 113.91% |
| 2005 | -0.23 SEK | 14.81% |
| 2004 | -0.27 SEK | -280.0% |
| 2003 | 0.15 SEK | -66.67% |
| 2002 | 0.45 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 1.21 SEK | 80.6% |
| 2024 Q2 | 1.10 SEK | -9.09% |
| 2024 Q3 | 0.36 SEK | -67.27% |
| 2023 FY | - SEK | -2.16% |
| 2023 Q2 | 0.80 SEK | -30.43% |
| 2023 Q1 | 1.15 SEK | -16.67% |
| 2023 Q4 | 0.67 SEK | -33.66% |
| 2023 Q3 | 1.01 SEK | 26.25% |
| 2022 Q2 | 0.78 SEK | 2.63% |
| 2022 Q3 | 0.79 SEK | 1.28% |
| 2022 FY | - SEK | 90.72% |
| 2022 Q1 | 0.76 SEK | 100.0% |
| 2022 Q4 | 1.38 SEK | 74.68% |
| 2021 Q4 | 0.38 SEK | -26.92% |
| 2021 FY | - SEK | 8.99% |
| 2021 Q1 | 0.50 SEK | 25.0% |
| 2021 Q2 | 0.54 SEK | 8.0% |
| 2021 Q3 | 0.52 SEK | -3.7% |
| 2020 Q4 | 0.40 SEK | 73.91% |
| 2020 Q1 | 0.48 SEK | -84.16% |
| 2020 Q2 | 0.90 SEK | 87.5% |
| 2020 Q3 | 0.23 SEK | -74.44% |
| 2020 FY | - SEK | -17.59% |
| 2019 Q3 | 0.44 SEK | -37.14% |
| 2019 FY | - SEK | -12.9% |
| 2019 Q1 | 0.41 SEK | -87.54% |
| 2019 Q4 | 3.03 SEK | 588.64% |
| 2019 Q2 | 0.70 SEK | 70.73% |
| 2018 Q2 | 0.64 SEK | 28.0% |
| 2018 Q4 | 3.29 SEK | 457.63% |
| 2018 FY | - SEK | 19.23% |
| 2018 Q1 | 0.50 SEK | -82.08% |
| 2018 Q3 | 0.59 SEK | -7.81% |
| 2017 Q1 | 0.49 SEK | -81.92% |
| 2017 Q4 | 2.79 SEK | 469.39% |
| 2017 Q3 | 0.49 SEK | -9.26% |
| 2017 FY | - SEK | -20.91% |
| 2017 Q2 | 0.54 SEK | 10.2% |
| 2016 Q4 | 2.71 SEK | 577.5% |
| 2016 Q2 | 0.44 SEK | -64.23% |
| 2016 Q1 | 1.23 SEK | -2.38% |
| 2016 FY | - SEK | 87.86% |
| 2016 Q3 | 0.40 SEK | -9.09% |
| 2015 Q1 | 0.50 SEK | -51.92% |
| 2015 FY | - SEK | -18.13% |
| 2015 Q4 | 1.26 SEK | 425.0% |
| 2015 Q3 | 0.24 SEK | -41.46% |
| 2015 Q2 | 0.41 SEK | -18.0% |
| 2014 Q2 | 0.21 SEK | -81.42% |
| 2014 Q3 | 0.17 SEK | -19.05% |
| 2014 Q4 | 1.04 SEK | 511.76% |
| 2014 Q1 | 1.13 SEK | 20.21% |
| 2014 FY | - SEK | 140.85% |
| 2013 FY | - SEK | -81.27% |
| 2013 Q2 | 0.18 SEK | -5.26% |
| 2013 Q4 | 0.94 SEK | 487.5% |
| 2013 Q3 | 0.16 SEK | -11.11% |
| 2013 Q1 | 0.19 SEK | 11.76% |
| 2012 Q4 | 0.17 SEK | 6.25% |
| 2012 Q3 | 0.16 SEK | -11.11% |
| 2012 Q2 | 0.18 SEK | -94.5% |
| 2012 Q1 | 3.27 SEK | 1262.5% |
| 2012 FY | - SEK | 330.68% |
| 2011 Q4 | 0.24 SEK | 41.18% |
| 2011 Q1 | 0.21 SEK | -71.62% |
| 2011 Q2 | 0.27 SEK | 28.57% |
| 2011 Q3 | 0.17 SEK | -37.04% |
| 2011 FY | - SEK | 60.0% |
| 2010 Q1 | 0.14 SEK | -64.1% |
| 2010 Q3 | 0.09 SEK | -42.5% |
| 2010 FY | - SEK | 30.95% |
| 2010 Q2 | 0.16 SEK | 14.29% |
| 2010 Q4 | 0.74 SEK | 704.35% |
| 2009 Q2 | 0.13 SEK | 8.33% |
| 2009 Q1 | 0.12 SEK | 0.0% |
| 2009 FY | - SEK | 0.0% |
| 2009 Q4 | 0.39 SEK | 333.33% |
| 2009 Q3 | 0.09 SEK | -30.77% |
| 2008 Q2 | 0.16 SEK | 0.0% |
| 2008 FY | - SEK | 82.61% |
| 2007 FY | - SEK | 618.75% |
| 2006 FY | - SEK | 113.91% |
| 2005 FY | - SEK | 14.81% |
| 2004 FY | - SEK | -280.0% |
| 2003 FY | - SEK | -66.67% |
| 2002 FY | - SEK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AcuCort AB | -0.16 SEK | 2362.5% |
| AlzeCure Pharma AB (publ) | -0.60 SEK | 703.333% |
| Enzymatica AB (publ) | -0.28 SEK | 1392.857% |
| Enorama Pharma AB (publ) | -1.61 SEK | 324.845% |
| Gabather AB (publ) | -0.65 SEK | 656.923% |
| Klaria Pharma Holding AB (publ.) | -0.36 SEK | 1105.556% |
| Moberg Pharma AB (publ) | -1.33 SEK | 372.18% |
| Nanexa AB (publ) | -1.09 SEK | 432.11% |
| Newbury Pharmaceuticals AB (publ) | -0.72 SEK | 602.778% |
| ODI Pharma AB | 0.02 SEK | -15370.085% |
| Orexo AB (publ) | -3.73 SEK | 197.051% |
| Probi AB (publ) | 1.48 SEK | -144.595% |
| Swedencare AB (publ) | 0.37 SEK | -878.378% |
| Swedish Orphan Biovitrum AB (publ) | 7.47 SEK | 51.539% |
| Toleranzia AB | -0.06 SEK | 6564.286% |
| Vivesto AB | -0.74 SEK | 589.189% |